Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724972 | SCV000332827 | uncertain significance | not provided | 2017-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724972 | SCV000532289 | likely benign | not provided | 2020-04-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088245 | SCV000751604 | likely benign | Duchenne muscular dystrophy | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002392795 | SCV002672960 | likely benign | Cardiovascular phenotype | 2019-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001833314 | SCV002087749 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-05-29 | no assertion criteria provided | clinical testing |